QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online October 11, 2005
doi: 10.1242/10.1242/jcs.02615

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tumbarello, D. A. Articles by Turner, C. E. Search for Related Content PubMed PubMed Citation Articles by Tumbarello, D. A. Articles by Turner, C. E.

Regulation of paxillin family members during epithelial-mesenchymal transformation: a putative role for paxillin

Department of Cell and Developmental Biology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA

^* Author for correspondence (e-mail: turnerce{at}upstate.edu)

Accepted 3 August 2005

Epithelial-mesenchymal transformation (EMT) and the resulting induction of cell motility are essential components of tissue remodeling during embryonic development and wound repair, as well as tumor progression to an invasive metastatic phenotype. Paxillin, a multi-domain adaptor and phosphoprotein has previously been implicated in integrin signaling and cell motility. In this report we characterize a novel paxillin gene product, paxillin , generated from an evolutionarily conserved internal translation initiation site within the full-length paxillin mRNA. Paxillin , which lacks the key phosphorylation sites Y31 and Y118 as well as the ILK and actopaxin binding LD1 motif, exhibits a restricted distribution to epithelial cell types and is downregulated during TGF-ß1-induced EMT of normal murine mammary gland (NMuMG) epithelial cells. Interestingly, Hic-5, a paxillin superfamily member, exhibits a reciprocal protein expression profile to paxillin . In addition, paxillin expression is maintained following NMuMG differentiation in a 3D collagen I gel while other focal adhesion components are downregulated. Paxillin protein expression coincided with reduced paxillin tyrosine phosphorylation in NMuMG cells and paxillin overexpression in CHO.K1 cells inhibited adhesion-mediated tyrosine phosphorylation of paxillin. Forced expression of paxillin in NMuMG cells suppressed cell migration whereas Hic-5 overexpression stimulated motility. Together our data support a role for paxillin as a naturally occurring functional antagonist of paxillin signaling potentially through suppression of a Crk-mediated pathway during processes associated with cell migration.

Key words: Cell migration, Actin cytoskeleton, Focal adhesion, Crk, Tyrosine phosphorylation, Hic-5

This article has been cited by other articles:

				K. Lange, M. Kammerer, F. Saupe, M. E. Hegi, S. Grotegut, E. Fluri, and G. Orend Combined Lysophosphatidic Acid/Platelet-Derived Growth Factor Signaling Triggers Glioma Cell Migration in a Tenascin-C Microenvironment Cancer Res., September 1, 2008; 68(17): 6942 - 6952. [Abstract] [Full Text] [PDF]

				R. Wade, N. Brimer, and S. Vande Pol Transformation by Bovine Papillomavirus Type 1 E6 Requires Paxillin J. Virol., June 15, 2008; 82(12): 5962 - 5966. [Abstract] [Full Text] [PDF]

				R. Jagadeeswaran, H. Surawska, S. Krishnaswamy, V. Janamanchi, A. C. Mackinnon, T. Y. Seiwert, S. Loganathan, R. Kanteti, T. Reichman, V. Nallasura, et al. Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion Cancer Res., January 1, 2008; 68(1): 132 - 142. [Abstract] [Full Text] [PDF]

				Y. H. Lee, U. S. Kayyali, A. M. Sousa, T. Rajan, R. J. Lechleider, and R. M. Day Transforming Growth Factor-beta1 Effects on Endothelial Monolayer Permeability Involve Focal Adhesion Kinase/Src Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 485 - 493. [Abstract] [Full Text] [PDF]

				C. Avraamides, M. E. Bromberg, J. P. Gaughan, S. M. Thomas, A. Y. Tsygankov, and T. S. Panetti Hic-5 promotes endothelial cell migration to lysophosphatidic acid Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H193 - H203. [Abstract] [Full Text] [PDF]

				S. Hiscox, L Morgan, T. Green, and R. I Nicholson Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer Endocr. Relat. Cancer, December 1, 2006; 13(Supplement_1): S53 - S59. [Abstract] [Full Text] [PDF]